-
Innovation Ranking
NewInnovation Ranking – Voyager Therapeutics Inc
Voyager Therapeutics Inc (Voyager) is a gene therapy company that discovers, develops and commercializes therapies to treat severe neurological diseases. It is evaluating VY-AADC program for the treatment of advanced Parkinson’s disease; VY-SOD102 against monogenic amyotrophic lateral sclerosis (ALS); VY-HTT01 to treat Huntington’s disease and VY-FXN01 program targeting Friedreich's ataxia. The company is also investigating therapies against tauopathies including Alzheimer’s disease (AD), frontotemporal lobar degeneration (FTD), Pick’s disease, progressive supranuclear palsy (PSP) and corticobasal degeneration. It works in collaboration with...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Voyager-V1 in Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Voyager-V1 in Colorectal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Voyager-V1 in Colorectal Cancer Drug Details: Voyager-V1 is under development for...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Voyager-V1 in Endometrial Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Voyager-V1 in Endometrial Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Voyager-V1 in Endometrial Cancer Drug Details: Voyager-V1 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Voyager-V1 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Voyager-V1 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Voyager-V1 in Solid Tumor Drug Details: Voyager-V1 is under development for...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Voyager-V1 in Relapsed Multiple Myeloma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Voyager-V1 in Relapsed Multiple Myeloma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Voyager-V1 in Relapsed Multiple Myeloma Drug Details: Voyager-V1 is under development...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Voyager-V1 in Refractory Multiple Myeloma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Voyager-V1 in Refractory Multiple Myeloma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Voyager-V1 in Refractory Multiple Myeloma Drug Details: Voyager-V1 is under development...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Voyager-V1 in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Voyager-V1 in Non-Small Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Voyager-V1 in Non-Small Cell Lung Cancer Drug Details: Voyager-V1 is...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Voyager-V1 in Head And Neck Squamous Cell Carcinoma (HNSC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Voyager-V1 in Head And Neck Squamous Cell Carcinoma (HNSC) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Voyager-V1 in Head And Neck Squamous...
-
Product Insights
Voyager Wind Project
Voyager Wind Project is an Onshore Wind project located in California, United States. The project is owned and developed by Terra-Gen LLC. The project is currently partially active. Empower your strategies with our Voyager Wind Project report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be...